Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Profit After Tax (2019 - 2025)

Historic Profit After Tax for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$39.7 million.

  • Legend Biotech's Profit After Tax rose 6833.01% to -$39.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$266.0 million, marking a year-over-year decrease of 3072.13%. This contributed to the annual value of -$177026.0 for FY2024, which is 6584.18% up from last year.
  • Per Legend Biotech's latest filing, its Profit After Tax stood at -$39.7 million for Q3 2025, which was up 6833.01% from -$125.4 million recorded in Q2 2025.
  • Legend Biotech's 5-year Profit After Tax high stood at $26284.0 for Q4 2024, and its period low was -$199.1 million during Q2 2023.
  • Its 5-year average for Profit After Tax is -$83.9 million, with a median of -$88.3 million in 2021.
  • Its Profit After Tax has fluctuated over the past 5 years, first plummeted by 3557017.6% in 2022, then surged by 11814.97% in 2024.
  • Legend Biotech's Profit After Tax (Quarter) stood at -$88.3 million in 2021, then plummeted by 53.82% to -$135.9 million in 2022, then surged by 99.89% to -$144818.0 in 2023, then surged by 118.15% to $26284.0 in 2024, then plummeted by 151100.61% to -$39.7 million in 2025.
  • Its Profit After Tax stands at -$39.7 million for Q3 2025, versus -$125.4 million for Q2 2025 and -$100.9 million for Q1 2025.